Canlan Ice Sports Corp. (ICE)
Toronto Exchange · Canada · prices in CAD · close of 21 Oct 2026
Key indicators
| Last close | CAD 4.400 |
|---|---|
| 52-week range | 3.950 – 5.250 |
| Return, 1 month / 3 months | +6.5% / −0.8% |
| Return, 1 year / 3 years | +10.7% / +41.0% |
| Trend | Uptrend |
| RSI (14) | 77 |
| Volatility (1 year) | 40.2% |
| Worst drawdown (1 year) | -11.6% |
| Average daily value traded | 0.00M CAD |
| Dividend yield | 14.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Canlan Ice Sports Corp. owns and operates indoor ice rink and sports facility complexes in Canada and the United States. The company runs recreational hockey leagues, adult and youth skating programs, tournaments and camps at its arenas, and it also offers food and beverage service and sports retail at some locations. Its customers are mainly amateur athletes, teams and families who rent ice time or join organized leagues. Canlan Ice Sports is based in Burnaby, British Columbia.
Canlan Ice Sports Corp. trades under the code ICE on the Toronto Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Canlan Ice Sports Corp. (ICE) trades on the Toronto Exchange in Canada. It last closed at CAD 4.400 on 21 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 403 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.7% and over the last three months it fell 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.8% | ||
| From 52-week high | -11.1% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.8% | ||
| 6-month return | 10.4% | ||
| 12-month return, skipping the last month | 3.9% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.6% | ||
| Liquidity | 4 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M CAD | ||
| Zero-volume days | 51.7% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 14.3% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +3.3% |
|---|---|
| 1 month | +6.5% |
| 3 months | −0.8% |
| 6 months | +10.4% |
| 1 year | +10.7% |
| 3 years | +41.0% |
| 5 years | +70.7% |
Signals
| 50-day / 200-day average | 4.245 / 4.197 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.038 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Sep 2026 | CAD 0.0400 |
| 30 Jun 2026 | CAD 0.0300 |
| 31 Mar 2026 | CAD 0.0300 |
| 31 Dec 2025 | CAD 0.0300 |
| 31 Oct 2025 | CAD 0.5000 |
| 29 Sep 2025 | CAD 0.0300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.